| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/23/2005 | EP1507528A2 Methods for using jnk inhibitors for treating or preventing disease-related wasting |
| 02/23/2005 | EP1286986B1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain |
| 02/23/2005 | EP1177177B1 Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands |
| 02/23/2005 | EP1140845B1 Susbstituted pyridine herbicides |
| 02/23/2005 | EP1107962B1 Quinolin-2-one derivatives useful as anticancer agents |
| 02/23/2005 | EP0947507B1 Novel tetrahydrobenzindolone derivatives |
| 02/23/2005 | CN1585772A Chemokine receptor antagonists and methods of use thereof |
| 02/23/2005 | CN1585768A Pyrazole derivatives as psychopharmaceuticals |
| 02/23/2005 | CN1585763A Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
| 02/23/2005 | CN1585762A Pyridine derivatives as NMDA receptor ligands |
| 02/23/2005 | CN1585757A Oligopeptides and compositions containing them as cathepsin S inhibitors |
| 02/23/2005 | CN1585754A Quinazoline derivatives as antitumor agents |
| 02/23/2005 | CN1585752A 4, 4-difluoro-1, 2, 3, 4-tetrahydro-5H-1-benzazepine derivatives or salts thereof |
| 02/23/2005 | CN1585751A 喹啉化合物 Quinoline compound |
| 02/23/2005 | CN1585749A Cannabinoid receptor ligands |
| 02/23/2005 | CN1585748A NK1 antagonists |
| 02/23/2005 | CN1585747A Azetidinyl diamines useful as ligands of the nociceptin receptor ORL-1 |
| 02/23/2005 | CN1585746A Beta-amyloid protein production/secretion inhibitors |
| 02/23/2005 | CN1585742A Aryl aniline beta-2 adrenergic receptor agonists |
| 02/23/2005 | CN1585643A Benzotriazepines as gastrin and cholecystokinin receptor ligands |
| 02/23/2005 | CN1583772A Organic metal complex and organic electroluminescent apparatus containing it |
| 02/23/2005 | CN1583742A Method for preparing 4-piperidyl piperidine |
| 02/23/2005 | CN1190432C Piperazing derivatives as 5-HTIB antagonists |
| 02/23/2005 | CN1190427C Method for preparing pyrimidine derivative |
| 02/23/2005 | CN1190424C Quinoline-containing Alpha-ketoamide cysteine and serine protease inhibitors |
| 02/23/2005 | CN1190423C Heteroycle derivatives and drugs |
| 02/23/2005 | CN1190197C Use of cyanoquinolines for treating or inhibiting colonic polyps |
| 02/22/2005 | US6858740 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 02/22/2005 | US6858739 Indole and benzimidazole 15-lipoxygenase inhibitors |
| 02/22/2005 | US6858738 Process for making amlodipine, derivatives thereof, and precursors therefor |
| 02/22/2005 | US6858641 Substituted indolinones |
| 02/22/2005 | US6858638 Substituted indazoles, compositions containing them, method of production and use |
| 02/22/2005 | US6858635 Photoreceptive detectors such as 2-(4-(4-((5S)-5-((Acetylamino )methyl)-2-oxo-3-oxazolidinyl)-2-fluorophenyl)-1-piperazinyl)-2-oxoethyl-4 -azido-2-hydroxy-5-iodobenzoate, used for analyzing binding in grampositive and negative bacteria |
| 02/22/2005 | US6858630 Administering substituted naphthimidazole derivative for therapy of thrombocytopenia |
| 02/22/2005 | US6858629 Heteroaryloxy propanolamines, preparation method and pharmaceutical compositions containing same |
| 02/22/2005 | US6858628 Substituted cyclic amine metalloprotease inhibitors |
| 02/22/2005 | US6858626 Cyclic hydroxamic acid as metalloproteinase inhibitors |
| 02/22/2005 | US6858625 Quinolinecarboxylic acid derivative or salts thereof |
| 02/22/2005 | US6858623 Amidino and guanidino peptidyl compounds |
| 02/22/2005 | US6858617 Substituted imidazole compounds |
| 02/22/2005 | US6858614 Such as 4-(4-hydroxyphenyl)butylamidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride; time-release agents; for treating chronic bronchitis, emphysema, cystic fibrosis, and eye disorders |
| 02/22/2005 | US6858608 Chemical derivatives and their application as antitelomerase agents |
| 02/22/2005 | US6858606 Nitrogen compounds such as 1-(2-(4-(N'-(3-Methyl-benzylidene)-hydrazino)-6-morpholin-4-yl-pyrimidin-2 -yloxy)-ethyl)-1H-pyridin-2-one, used to control interleukin production; antiinflammatory agents |
| 02/22/2005 | US6858603 Acetindine derivatives, their preparation and medicaments containing them |
| 02/22/2005 | CA2218493C Benzimidazole compounds and their use as modulators of the gabaa receptor complex |
| 02/17/2005 | WO2005014755A1 Alkynyl group-substituted condensed heterocyclic compound, method for producing same, and organic electroluminescent device using same |
| 02/17/2005 | WO2005014723A1 Cyanin-type compounds having an alkynyl linker arm |
| 02/17/2005 | WO2005014584A1 3-(indol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones,3-(benzimidazol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones, and 3-(indolin-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones; their preparation and use as modulators of apoptosis |
| 02/17/2005 | WO2005014582A1 Quinazoline derivatives as angiogenesis inhibitors |
| 02/17/2005 | WO2005014581A2 Lanthanide complexes preparation and uses thereof |
| 02/17/2005 | WO2005014579A1 Imidazol derivatives of piperdine as histamine antagonists |
| 02/17/2005 | WO2005014578A1 Phenylsulfonyl compounds as antipsychotic agents |
| 02/17/2005 | WO2005014577A1 Novel farnesyl protein transferase inhibitors as antitumor agents |
| 02/17/2005 | WO2005014575A1 Quinoline 4-carboxamide derivatives and their use as neurokinin 3 (nk-3) receptor antagonists |
| 02/17/2005 | WO2005014574A1 Substituted lactams and their use as anti-cancer agents |
| 02/17/2005 | WO2005014573A1 Anthelmintic and insecticide pyrimidine derivatives |
| 02/17/2005 | WO2005014571A1 Substituted piperidines as histamine h3 receptor ligands |
| 02/17/2005 | WO2005014558A1 Condensed pyramidine compounds as inhibitors of voltage-gated ion channels |
| 02/17/2005 | WO2005014555A1 4,5-dihydro-imidazole as p2x7 ion channel blockers |
| 02/17/2005 | WO2005014554A1 1h-indazole-3-carboxamide compounds as mapkap kinase modulators |
| 02/17/2005 | WO2005014552A1 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors |
| 02/17/2005 | WO2005014542A2 Novel n-substituted indolyl-3-glyoxylic acid amides, use thereof as a medicament against cancer, and method for the production thereof |
| 02/17/2005 | WO2005014540A1 Cyclic amine base-1 inhibitors having a heterocyclic substituent |
| 02/17/2005 | WO2005014539A2 Pyrrole-based hmg-coa reductase inhibitors |
| 02/17/2005 | WO2005013998A1 Quinazoline derivatives as inhibitors of vegf receptor tyrosine kinases |
| 02/17/2005 | WO2005013995A1 4-substituted 7-alkoxy-2-aminosulfonyl-1,2-dihydro-phtalazin derivatives as phosphodiesterase 4 inhibitors for the treatment of allergies and inflammations |
| 02/17/2005 | WO2005013991A1 Dry syrup containing loratadine |
| 02/17/2005 | WO2005013990A1 2-`4-(hydroxymethyl-phenylamino) -piperidine-1-yl!-n- (9h-carbazol-3-yl) - acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity |
| 02/17/2005 | WO2005013988A1 2-`4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatement of obesity |
| 02/17/2005 | WO2005013985A1 Treatment for alzheimer's disease and related conditions |
| 02/17/2005 | WO2005013982A1 Aminotriazole compounds useful as inhibitors of protein kinases |
| 02/17/2005 | WO2005013977A1 Indol-5-yl sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 02/17/2005 | WO2005013974A1 1-sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands |
| 02/17/2005 | WO2005013914A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 02/17/2005 | WO2005013909A2 Novel cathepsin k inhibitors |
| 02/17/2005 | WO2004110993A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 02/17/2005 | WO2004110344A3 New azetidine compounds |
| 02/17/2005 | WO2004099131A3 Compounds having a fused, bicyclic moiety for binding to the minor groove of dsdna |
| 02/17/2005 | WO2004096982A3 Antibacterial agents |
| 02/17/2005 | WO2004089306A3 Di-aryl substituted triazole modulators of metabotropic glutamate receptor-5 |
| 02/17/2005 | WO2004084813A3 Chemical compounds |
| 02/17/2005 | WO2004078114A3 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-ii receptor antagonists. |
| 02/17/2005 | WO2004078101A3 Urea derivatives having vanilloid receptor antagonist activity |
| 02/17/2005 | WO2004070050A3 Cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors |
| 02/17/2005 | WO2003106449A8 Novel aryl-{4-halo-4-[heteroarylmethylamino)-methyl]-piperidin-1-yl}-methanone derivatives, methods for production and use thereof as medicaments |
| 02/17/2005 | WO2003104332A8 Compositions and inks containing disazo dyes |
| 02/17/2005 | US20050038247 topoisomerase inhibitors such as [5-(4-Cyclopropylcarbamoyl-imidazol-1-yl)-7-pyrimidin-2-yl-1H-benzoimidazol-2-yl]-carbamic acid ethyl ester, used for prophylaxis of bacterial infections in mammals |
| 02/17/2005 | US20050038246 PPAR active compounds |
| 02/17/2005 | US20050038243 2, 4-pyrimidinediamine compounds and their uses |
| 02/17/2005 | US20050038101 Substituted 2 5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases |
| 02/17/2005 | US20050038100 Eating disorders; anticholesterol agents; hypotensive agents; sleep disorders; hyperphagia |
| 02/17/2005 | US20050038099 3-Amido-5-substituted pyrazole derivatives and related compounds useful as bradykinin B1 receptor antagonists to relieve adverse symptoms in mammals mediated, at least in part, by bradykinin B1 receptor including pain, inflammation, septic shock, scarring process |
| 02/17/2005 | US20050038097 Modulate and/or inhibit tyrosine kinase signal transduction; antiproliferative agents; treating, prevention of cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis |
| 02/17/2005 | US20050038095 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 02/17/2005 | US20050038087 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments |
| 02/17/2005 | US20050038085 Substituted benzimidazole antiviral agents |
| 02/17/2005 | US20050038084 Phenylalanine enamide derivatives |
| 02/17/2005 | US20050038081 amidation of a heteroary substituted oxoaminobenzoic acid with an amine; for treatment of psoriasis and rheumatoid arthritis using e.g. N-(3-dimethylaminophenyl)-3-(3-methoxybenzamido)-4-methylbenzamide |
| 02/17/2005 | US20050038076 Process for preparing isomerically pure prodrugs of proton pump inhibitors |
| 02/17/2005 | US20050038074 Kinesin spindle protein (KSP) inhibitors, e.g., 4-(2,5-Difluorophenyl)-N-[(3S,4S)-3-fluoropiperidin-4-yl]-2-hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1N-pyrrole-1-carboxamide; antiproliferative and -carcinogenic agents |